24 %Among 642 HIV-positive female sex workers eligible for IPT evaluation, 157 (24%) appropriately exited the IPT care cascade.
KenyaVIH/sidaobservé between March 2000 and January 2010publié 2017Journal of acquired immune deficiency syndromes (1999)europe_pmcdocument de 9 observationsDOI 10.1097/qai.0000000000001461
0,003 p-valueWomen infected with HIV-1 subtype D had a faster rate of CD4 cell count decline compared with those infected with subtype A (P=.003).
KenyaVIH/sidapublié 2007The Journal of infectious diseaseseurope_pmcdocument de 2 observations
0,58 aORAmong adolescent girls and young women aged 13–24 in Kenya, having gender-equitable attitudes was associated with reduced odds of adolescent pregnancy (adjusted odds ratio: 0.58).
Kenyaadolescent pregnancyobservé 2018–19publié 2025AIDS and behaviorPubMeddocument de 12 observations
78,3 %Compared to partners with an HIV-negative result, condom use was higher when men refused to self-test (56.3% vs. 78.3%).
KenyaVIH/sidapublié 2020Journal of the International AIDS SocietyPubMeddocument de 15 observations
281 participantsTwo hundred eighty-one participants were screened between 2003 and 2006 for two clinical trials.
KenyaVIH/sidaobservé 2003 and 2006publié 2011PloS oneeurope_pmcdocument de 7 observationsDOI 10.1371/journal.pone.0014580
54 %The prevalence of allele-specific antibody reactivity to MSP3 was 54% for 3D7-specific and 41% for K1-specific in a Kenyan cohort.
Kenyapaludismepublié 2007Parasite immunologyeurope_pmcdocument de 3 observations
82 600 000 live birthsIn 2007, 82.6 million live births occurred among pregnancies in areas with Plasmodium falciparum and/or Plasmodium vivax transmission.
Kenyapaludismeobservé 2007publié 2010PLoS medicineeurope_pmcdocument de 11 observations
49,9 %Among 1988 postpartum mothers in Kenya, 49.9% were living with HIV.
KenyaVIH/sidapublié 2026AIDS and behaviorPubMeddocument de 8 observations
59,3 %Among women who engaged in pica, 59.3% reported amylophagy.
Kenyapicapublié 2019International journal of environmental research and public healtheurope_pmcdocument de 6 observations
33,7 per_100_person-yearsAmong MSM in a HIV vaccine feasibility cohort study in coastal Kenya between June 2017 and June 2019, the incidence rate of loss to follow-up (LTFU) was 33.7 per 100 person-years.
KenyaVIH/sidaobservé June 2017 to June 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 4 observations
31,7 per_1000In Kipsamoite, highland Kenya, malaria incidence peaked at 31.7 per 1,000 persons in June 2004.
Kenyapaludismeobservé June 2004publié 2020The American journal of tropical medicine and hygienePubMeddocument de 4 observations
9 %Globally, the vertical transmission rate of HIV is 9%.
KenyaVIH/sidapublié 2023PLoS ONEOpenAlexdocument de 5 observations
1,28 odds_ratioIncident HSV-2 was associated with increased likelihood of bacterial vaginosis (adjusted OR, 1.28; 95% CI, 1.05–1.56; P = .01).
KenyaHerpes simplex virus type 2 · vaginose bactériennepublié 2014The Journal of infectious diseaseseurope_pmc
90 %The First Response™ Malaria Ag PAN/Pf rapid diagnostic test demonstrated a sensitivity of 90% compared to peripheral blood quantitative polymerase chain reaction in diagnosing malaria in pregnancy.
Kenyapaludismeobservé April 2023-March 2024publié 2026BMC infectious diseasesPubMeddocument de 14 observations
1,5 odds_ratioThe overall abundance of anopheline mosquitoes had an odds ratio of 1.5 for association with severe malaria in Kilifi District, Kenya.
Kenyaanopheline mosquitoes · paludismepublié 1999The American journal of tropical medicine and hygieneeurope_pmcdocument de 5 observationsDOI 10.4269/ajtmh.1999.60.781
Pfmdr1 NFD and NYD haplotypes increased between 2012 and 2017 in Kenya.
Kenyapaludismeobservé 2012-2017publié 2025Malaria journalPubMeddocument de 14 observations
180 copies/mlThe primary clinical outcome was detectable plasma viral load defined as ≥180 copies/ml.
KenyaVIH/sidapublié 2016AIDS and behavioreurope_pmc
1,66 aPRAmong participants in Kenya, Uganda, Tanzania, and Nigeria between 19 July 2022 and 1 March 2024, adjusted prevalence ratio for SARS-CoV-2 infection was 1.66 among those who received at least one dose of a COVID-19 vaccine compared to those who received no doses.
Kenya · Nigeria · Ouganda · TanzanieCOVID-19observé 19 July 2022 to 1 March 2024publié 2025BMC infectious diseasesPubMeddocument de 8 observations
751 testsOf 792 point-of-care HIV tests with documented maternal notification, 751 (94.8%) resulted in notification on the same day as sample collection.
KenyaVIH/sidapublié 2020PloS onePubMeddocument de 13 observations
88 %Toluidine blue 0.05% vital staining had a negative predictive value of 88% (95% CI, 80%–94%) for detecting ocular surface squamous neoplasia (OSSN).
Kenyaocular surface squamous neoplasia (OSSN)observé July 2012 through July 2014publié 2015JAMA ophthalmologyeurope_pmcdocument de 11 observations
19,62 %The unadjusted national HIV prevalence of people who inject drugs (PWIDs) in Kenya was 19.62%.
KenyaVIH/sidapublié 2021BMC public healthPubMeddocument de 17 observations
Indoor residual house-spraying (IRS) and insecticide-treated bednets (ITNs) are used for malaria prevention in the highland districts of Gucha and Kisii in Kenya.
Kenyapaludismepublié 2002Health policy and planningeurope_pmcdocument de 6 observationsDOI 10.1093/heapol/17.2.144
In a 3-year longitudinal cohort of 300 Kenyan children, malaria transmission declined markedly.
Kenyapaludismepublié 2017The Journal of infectious diseaseseurope_pmcdocument de 7 observationsDOI 10.1093/infdis/jix370
13,41 pointsAdolescents and young adults living with HIV who had moderate-to-severe depression had a mean adherence self-efficacy score that was 13.41 points lower than those with none-or-mild depression.
Kenyadépression · VIH/sidapublié 2026PloS onePubMeddocument de 8 observations
4,8 %HIV prevalence among female sex workers less than 25 years of age in Nairobi decreased to 4.8% in 2016–2017.
KenyaVIH/sidaobservé 2016–2017publié 2021AIDS (London, England)PubMeddocument de 13 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.